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ABSTRACT
Background: Although hypertension is, in most cases, a controllable major risk factor in the development of 
cardiovascular disease, studies have demonstrated that hypertension remains poorly controlled in Portugal. Our 
aim was to evaluate the covariates associated with poor blood pressure (BP) control in a Portuguese hypertensive 
population. Patients and Results: We conducted a cross-sectional survey in a hospital hypertension outpatient 
clinic, located in the Eastern Central Region of Portugal. Patients attending the clinic from July to September 
2009 were asked to participate in a structured interview including medication adherence and knowledge about 
hypertension. Eligible participants were all adults aged 18 or over with an established diagnosis of arterial 
hypertension and had been on antihypertensive drug treatment for at least 6 months. Exclusion criteria were 
dementia, pregnancy, and breastfeeding. Detailed clinical information was prospectively obtained from medical 
records. A total of 197 patients meeting the inclusion criteria and consenting to participate completed the 
interview. Of these, only 33.0% had their BP controlled according to the JNC 7 guidelines. Logistic regression 
analysis revealed three independent predictors of poor BP control: living alone (OR = 5.3, P = 0.004), 
medication nonadherence (OR = 4.8, P < 0.001), and diabetes (OR = 4.4, P = 0.011). Predictors of medication 
nonadherence were: unawareness of target BP values (OR = 3.7, P < 0.001), a report of drug side effects (OR = 
3.7, P = 0.002), lack of BP monitoring (OR = 2.5, P = 0.015) and unawareness of medication indications (OR 
= 2.4, P = 0.021), and of hypertension risks (OR = 2.1, P = 0.026). Conclusions: Poor medication adherence, 
lack of information about hypertension, and side effects should be considered as possible underlying causes of 
uncontrolled BP and must be addressed in any intervention aimed to improve BP control.
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INTRODUCTION
Hypertension is a major risk factor in the development 
of  cardiovascular disease and one of  the most important 
public health problems in Portugal affecting over 3 
million Portuguese adults (about 30% of  the Portuguese 
population).[1] In well-conducted clinical trials, numerous 
drugs and combination therapies have demonstrated their 
ability to reduce blood pressure (BP), with rates of  BP 
control ranging from 45% to 66%.[2, 3] However, in the 
clinical practice, control rates of  high BP are expected 
to be lower than those observed in the high motivated, 
closely controlled, and monitored patient population of  the 
clinical trials. In a recently published survey,[1] only 28.9% 
Portuguese treated hypertensives had their BP controlled 
(<140/90 mmHg). This fi gure is even lower in the Central 
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Region of  Portugal, where only 26.1% of  the total number 
of  treated hypertensives have their BP controlled.[1] One 
of  the major drawbacks of  this Portuguese survey relies 
on the defi nition of  controlled hypertension, which was 
considered as the mean systolic BP <140 mmHg and 
diastolic BP of  <90 mmHg. This defi nition does not take 
into account the seventh report of  the Joint National 
Committee on the Prevention, Detection, Evaluation, and 
Treatment of  High Blood Pressure (JNC 7), according to 
which for hypertensive patients who also have diabetes or 
chronic kidney disease (CKD) target levels of  BP are even 
lower (<130/80 mmHg).
The Eastern Central Region of  Portugal possesses a 
university teaching hospital at Covilhã, named Cova 
da Beira Hospital Centre, with an important secondary 
care hypertension/dyslipidemia outpatient clinic, which 
serves a significant hypertensive population of  the 
District of  Castelo Branco. To better understand the 
unsatisfactory levels of  BP control of  this hypertensive 
population and focus efforts on improving them, it 
would be useful to know the extent to which hypertensive 
patients with different risks for vascular complications 
are not satisfactorily controlled and to identify some 
possible factors that may be involved in inadequate BP 
control. Accordingly, we conducted a cross-sectional 
study to evaluate the level of  BP control in hypertensive 
patients attending the mentioned hospital hypertension/
dyslipidemia outpatient clinic and to recognize some 
factors that may underlie insuffi cient BP control and poor 
medication adherence.
PATIENTS AND METHODS
Settings and study design
In July–September 2009, we conducted a cross-sectional 
survey in a secondary care hypertension/dyslipidemia 
clinic in the university teaching hospital of  Cova da Beira 
Hospital Centre, Covilhã, District of  Castelo Branco, 
located in the Eastern Central Region of  Portugal. This 
outpatient clinic is one of  the most important clinics of  this 
region in Portugal in the fi eld of  hypertension/dyslipidemia 
and serves a signifi cant hypertensive population of  Covilhã 
Area, with a population of  35 thousand inhabitants.
Study population
All hypertensive patients attending the medical clinic 
during that period were asked to complete the structured 
interview. Patients were asked to complete a structured 
questionnaire on demography, medication adherence, 
and knowledge about target BP values, hypertension 
risks, indications of  antihypertensive medication, and the 
presence of  drug side effects. Subjects were also asked 
whether they used a home BP monitoring device and/or 
whether they measure their BP regularly. The study was 
approved by the Institutional Ethics Committee for the 
use of  humans in research, and written informed consent 
was obtained from all participants before their enrolment 
in the study.
Eligible participants were all adults aged 18 or over with 
an established medical diagnosis of  arterial hypertension 
(BP measurements in the clinic of  systolic BP (SBP) 
≥140 mmHg and/or diastolic BP (DBP) ≥90 mm 
Hg). Furthermore, all included patients had been on 
established antihypertensive drug treatment for at least 6 
months. Exclusion criteria were dementia, pregnancy, and 
breastfeeding.
Blood Pressure measurements
BP was measured in a seated position after a 5-min 
rest period, using a mercury sphygmomanometer or 
semi-automatic device, the mean of  two consecutive 
measurements being recorded. According to the JNC 7 
guidelines, hypertensive patients without diabetes and 
CKD with BP <140/90 mmHg were considered to have 
their BP controlled. For hypertensive patients with diabetes 
or CKD, BP control was defi ned as BP measurements 
<130/80 mmHg.
Medication adherence, hypertension knowledge, and 
management evaluation
Assessment of  antihypertensive medication adherence 
was determined using the instrument validated by 
Morisky et al.[4, 5] Poor medication adherence was defi ned 
as answering yes to three or more of  fi ve questions. We 
also evaluated patient knowledge of  target BP values and 
of  the potential impact of  hypertension on the morbidity 
and mortality associated with stroke, cardiac disease, and 
kidney disease. Patients were considered knowledgeable 
of  target BP values if  they knew both target BP fi gures 
(<140/90 mmHg for hypertensive patients without 
diabetes and CKD and <130/<80 mmHg for hypertensive 
patients with diabetes or CKD). They were considered 
knowledgeable of  the negative impacts of  hypertension 
to health if  they mentioned at least two potential major 
negative consequences of  uncontrolled hypertension. It 
was considered that BP was measured regularly if  values 
were recorded at least once a month.
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Clinical parameters
Clinical data for this study, including BP measures, 
medications prescribed, and medical problems, were 
prospectively obtained from the Hospital Electronic 
Medical Records (HEMR) database. The HEMR database 
of  Cova da Beira Hospital Centre is comprised of  detailed 
patient-level clinical and administrative information of  all 
patients that have used this hospital at least once. Available 
information includes patient demographics, medical 
problems, various measures of  physiological status, and 
medications prescribed. This database is authorized by 
the Portugal Department of  Health, the government 
department responsible for public health issues, and patient 
data confi dentiality was ensured.
Statistical analysis
Demographic variables, clinical data, and BP values of  
hypertensive patients included in the study, as well as 
prescribing metrics were examined on a descriptive basis and 
expressed as the mean ± SD, frequency, and percentages. 
To test for differences between categorical variables 
χ2-test were used. Multivariate analyses were conducted 
using logistic regressions with the forward likelihood ratio 
(Forward:LR) selection algorithm. All statistical analyses 
were carried out using SPSS for Windows, version 17.0 
(SPSS Inc., Chicago, IL), and a P-value of  less than 0.05 
was considered to indicate statistical signifi cance.
RESULTS
A total of  222 patients attended the medical clinic during 
the recruitment period (from July 2009 to September 
2009), and all were assessed for eligibility. Of  these, 17 
were excluded from the study because they did not meet the 
inclusion criteria, 1 was excluded because of  breastfeeding, 
and 7 were excluded because they declined to participate 
(they did not sign the informed consent). Thus, a total of  
197 (89%) hypertensive patients met the inclusion criteria 
and consented to participate [Figure 1].
The overall mean age of  the included patients was 60 ± 
12 years, 40.1% being male and 59.9% female [Table 1]. 
Among these patients, 153 (77.7%) had neither diabetes 
nor CKD and were considered to have a target BP of  
<140/90 mmHg, whereas the remaining 44 (22.3%) had 
either diabetes and/or CKD and were considered to be 
controlled with a BP of  <130/80 mmHg. Most patients 
were long-term hypertensives, with 74.1% (146/197) of  
patients taking antihypertensive medications for at least 5 
years. Only four patients have been prescribed hypertensive 
medication for the fi rst time in the preceding 12 months. 
Overall, only 48.2% of  patients were considered to be 
highly adherent to antihypertensive medication. Other 
demographic and clinical characteristics, as well as results 
obtained in the structured interview are represented in 
Table 1. All variables listed in Table 1 were covariates in 
the analyses.
Overall, the mean systolic BP of  the 197 hypertensive 
patients included in our analysis was 141.8 ± 16.5 mmHg, 
and the mean diastolic BP was 85.8 ± 11.80 mmHg, with 
33.0% (65/197) patients attaining controlled BP according 
to JNC 7 guidelines. Among patients with neither diabetes 
nor CKD, 39.2% had their BP controlled, whereas among 
patients with one or both of  these pathologies this fi gure 
was 11.4% (P = 0.009). In all, 37.1% (73/197) patients 
attained BP values <140/90 mmHg.
Forward:LR logistic regression revealed that the covariates 
medication adherence (OR, 4.8; 95% CI, 2.4–9.5; P < 
0.001), marital status (OR, 5.3; 95% CI, 1.7–16.4; P < 
0.004), and diabetes (OR, 4.4; 95% CI, 1.4–13.5; P < 
0.011) were the independent variables that signifi cantly 
infl uenced BP control. Using the logistic regression 
coeffi cients (ln(OR)) for those covariates, the following 
signifi cant logistic regression model (G2 (3) = 46.054; 
P < 0.001; X2HL (4) = 4.152; P = 0.386; R
2
CS = 0.208; 
R2N = 0.290; R
2
MF = 0.184, where G
2 is the likelihood-
ratio goodness-of-fi t statistic, X2HL is the Hosmer and 
Lemeshow statistic, R2CS is the Cox and Snell R square, 
R2N is the Nagelkerke R square, and R
2
MF is the McFadden 




Figure 1: Diagram of patient enrollment.
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(1) where Pb is the probability of  a given patient to 
have uncontrolled BP, ADH is medication adherence (0, 
adherent; 1, nonadherent), MS is marital status (0, married; 
1, single, widowed, divorced, or separated), and DIAB is 
diabetes (0, without diabetes; 1, with diabetes).
This model has acceptable sensitivity (77.3%) and 
specifi city (63.1%), as well as an acceptable discrimination 
power (area under ROC curve = 0.764; P < 0.001).
Of  the three covariates fi guring in Eq. (1), medication 
adherence is the independent variable more likely to be 
favorably infl uenced by a health care professional team 
in order to enhance BP control. Thus, we determined 
the covariates that signifi cantly infl uence the dependent 
variable medication adherence. Forward:LR logistic 
regression revealed that knowledge of  target BP (OR, 
3.7; 95% CI, 1.9–7.4; P < 0.001), reporting of  drug side 
effects (OR, 3.7; 95% CI, 1.6–8.3; P < 0.002), measuring BP 
regularly (OR, 2.5; 95% CI, 1.2–5.2; P < 0.015), knowledge 
of  drug indications (OR, 2.4; 95% CI, 1.1–5.2; P < 0.021), 
and knowledge of  hypertension risks (OR, 2.1; 95% CI, 
1.1–4.2; P < 0.026) were the independent variables that 
signifi cantly infl uences medication adherence. Using the 
logistic regression coeffi cients (ln(OR)) for those covariates, 
the following signifi cant logistic regression model (G2 (5) 
= 54.446; P < 0.001; X2HL (7) = 2.448; P = 0.931; R
2
CS = 
0.241; R2N = 0.322; R
2




(2) where Pb is the probability of  a given patient to be 
nonadherent to medication, TBP, knows target BP (0, 
yes; 1, no); SE, reports side effects (0, no; 1, yes); BPR, 
measures BP regularly (0, yes; 1, no); DI, knows drug 
indications (0, yes; 1, no); and HTR, knows hypertension 
risks (0, yes; 1, no).
This model also revealed to have acceptable sensitivity 
(71.6%) and specifi city (72.6%), as well as an acceptable 
discrimination power (area under ROC curve = 0.788; P 
< 0.001).
All independent variables fi guring in Eq. (2) are amenable 
to improvement by team-based health care professionals’ 
Table 1: Patients demographics and clinical characteristics and data collected in the structured interview (n = 197)
Demographic/clinical characteristics Values
Gender, n (%)
     Male
     Female
79 (40.1)
118 (59.9)
Age, mean (SD) 59.5 (11.7)
Body mass index (kg/m2), mean (SD) 29.4 (4.8)
Married, n (%) 160 (81.2)
Education, n (%)
     Illiterate
     Elementary schooling
     High schooling





Current smoker, n (%) 17 (8.6)
Comorbid conditions, n (%)
     Cerebrovascular disease
     Chronic kidney disease
     Diabetes
     Heart failure
     Ischemic heart disease
     Myocardial infarction
     Left ventricular hypertrophy
     Dyslipidemia
     Metabolic syndrome











Number of years in antihypertensive drug treatment, mean (SD) 9.8 (7.7)
Low self-reported medication adherence, score ≥ 3, n (%) 102 (51.8)
Knowledge of target BP values, n (%) 117 (59.4)
Knowledge of hypertension risks, n (%) 108 (54.8)
Knowledge of drug indications, n (%) 139 (70.6)
Regular monitoring of BP, n (%) 139 (70.6)
Reported side effects, n (%) 45 (22.8)
Abbreviations: BP, Blood pressure; SD, standard deviation.
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performed in the middle-West of  France and involving 
1050 treated hypertensives, Ragot et al., reported that 39% 
of  patients had BP fi gures <140/90 mmHg and only 13% 
of  the diabetic population were normalized according to 
the international recommendations (<130/80 mmHg).
[11] In a more recent retrospective observational study 
conducted in the United States, Jackson et al.[9] reported 
a BP control of  49.3% in an after-JNC 7 cohort. In this 
cohort, a signifi cantly higher percentage of  nondiabetic 
patients achieved BP control compared with those with 
comorbid diabetes (60.9% vs. 29.4%). Similarly, Andros 
et al.[12] conducted a retrospective observational study of  
BP control in an insured diabetic population, obtaining a 
BP control rate (defi ned by JNC 7) of  28%, similar to the 
29.4% obtained by Jackson et al.[9] The results obtained in 
our study are similar to those reported by Ragot et al., in a 
middle-West French treated hypertensive population, for 
both patients without diabetes and CKD and patients with 
these pathologies.
The logistic regression analyses of  the study population 
revealed that the covariates medication adherence, marital 
status and diabetes signifi cantly infl uence BP control, such 
that the probability of  a nonadherent, unwed, diabetic 
patient to have uncontrolled hypertension is 98.6%. At 
the other end, the probability of  an adherent, married, 
nondiabetic patient to have uncontrolled hypertension is 
only 39.3%. Surely, there are more unstudied independent 
variables that significantly influence BP control (e.g., 
prescribed antihypertensive medication). For example, the 
possible existence of  clinical inertia and undertreatment 
must be analyzed in patients with diabetes or CKD. 
However, sensitivity, specifi city, and ROC curve analysis 
revealed an acceptable model performance.
Of  the three covariates significantly influencing 
BP control, the variable most likely to be favorably 
influenced by team-based health care professionals’ 
interventions is medication adherence. In patients with 
hypertension, medication nonadherence is a signifi cant, 
often unrecognized, risk factor that contributes to poor 
BP control, thereby contributing to the development 
of  further vascular disorders such as heart failure, 
coronary heart disease, renal insuffi ciency, and stroke.
[13] Antihypertensive medication adherence rates have 
differed widely depending on the population studied, and 
it is estimated to range between 50% and 70% in patients 
with treated hypertension.[14-16] Therefore, the percentage 
of  antihypertensive medication adherence found in 
our study is largely within the range reported in the 
literature.[17, 18] The importance of  improving adherence to 
antihypertensive medication has been addressed by JNC 
interventions in order to increase medication adherence 
and, thereby, BP control.
DISCUSSION
The results presented in this study describe some 
demographic and clinical characteristics of  hypertensive 
patients attending the medical consultation of  hypertension/
dyslipidemia in a university teaching hospital located in the 
Eastern Central Region of  Portugal, focusing on the level 
of  hypertension control and antihypertensive medication 
adherence. According to a survey conducted in 2003,[1] of  
the total number of  hypertensives in the Central Region 
of  Portugal prescribed with antihypertensives, only 26.1% 
had their BP measurements <140/90 mmHg, which is 
signifi cantly smaller than the 37.1% obtained in our study. 
This difference possibly points to an improved current 
care of  the hypertensives included in our study when 
compared to those included in the abovementioned survey. 
Increased awareness of  hypertension and the importance 
of  lower BP may have prompted Portuguese providers 
and patients to treat high BP more aggressively, especially 
after the publication of  the JNC 7 report in 2003. The 
issuing, in 03/31/2004, of  the legal document “Guidelines 
to detect, treat and control arterial hypertension”,[6] by the 
Department of  Health of  the Portuguese Government, 
defi nitely contributed to an evidence-based approach to 
the prevention, detection, evaluation, and treatment of  
high BP. These guidelines have many similarities with the 
JNC 7 report and were subsequently updated, in 2006, by 
the Portuguese Society of  Hypertension.[7] Till now, there 
was no prospective data about the percentage of  treated 
hypertensives in clinical practice, in this Portuguese region, 
with their BP controlled according to the JNC 7 guidelines. 
Our study revealed that 33.0% of  hypertensive patients 
had their BP controlled according to those guidelines, 
and that there was a signifi cantly greater BP control (P 
= 0.009) in patients without diabetes or CKD (39.2%) 
when compared to patients with diabetes and/or CKD 
(11.4%). To the best of  our knowledge, this prospective 
study presents for the fi rst time the percentage of  treated 
and controlled hypertensives, according to the JNC 7 
guidelines, in a Portuguese subpopulation. It should be 
noted that the reported levels of  BP control can vary 
greatly depending on the study population, methods, and 
time frame.[8, 9] In one study, on the basis of  data from the 
US National Health and Nutrition Examination Survey 
2003–2004, the BP control rate (to <140/90 mmHg) 
was 56.6% in treated hypertensives, and 37.5% in treated 
hypertensive persons with diabetes mellitus (for whom 
the goal BP is <130/80 mmHg).[10] In a regional survey 
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7, and emphasis has been put on the role of  all health 
care professionals, including pharmacists, to improve 
adherence to the treatment.[19]
Logistic regression revealed that knowledge of  target BP 
values, the presence of  drug side effects, measuring BP 
regularly, knowledge of  drug indications, and knowledge 
of  hypertension risks are the independent variables that 
signifi cantly infl uence medication adherence. According 
to our logistic regression model (Eq. (2)), the probability 
of  a hypertensive patient ignoring target BP values, drug 
indications and hypertension risks, reporting drug side 
effects and not monitoring BP regularly to be nonadherent 
is 97.4%. On the contrary, the probability of  a hypertensive 
patient knowing the target BP values, drug indications and 
hypertension risks, not presenting drug side effects and 
monitoring BP regularly to be nonadherent is only 17.6%.
Although a signifi cant percentage (70.6%) of  patients 
reported to measure BP regularly, only (P = 0.020) 59.4% 
were aware of  their target BP fi gures (systolic and diastolic). 
Self  and/or regular BP measurement is useful for the 
assessment of  the treatment effects by the doctor and is 
valuable for the patients in improving the management of  
their high BP. However, as many patients (40.6%) do not 
know their target BP values they cannot accurately report 
whether it is controlled. Therefore, a major implication 
of  our study is the need for education of  patients to 
their target BP fi gures so that they can correctly identify 
whether it is elevated or controlled. Likewise, our fi ndings 
also suggest the need to improve patient awareness of  the 
cardiovascular risks of  hypertension and of  the therapeutic 
indications and usefulness of  antihypertensives. It is 
worth noting that even though these patients have had 
hypertension for a long period (average number of  years 
in antihypertensive drug treatment was 9.8 ± 7.7 years), 
their knowledge is inadequate. Recent research points to the 
need to improve hypertension knowledge and awareness 
in order to increase medication adherence and BP control.
[20, 21] Continuing attention should be given to side effects 
of  antihypertensives, because they are one of  the most 
important causes of  nonadherence.[22] Adverse events 
during antihypertensive treatment are not entirely avoidable 
because they are partly psychological and are also reported 
during administration of  placebo.[22] However, great effort 
should be dedicated to limitation of  drug-related side 
effects and preservation of  the quality of  life either by 
switching treatment from the responsible drug to another 
agent or by avoiding unnecessary increases of  the dose by 
using combination therapy.[23] Discussion of  patients’ side 
effects and concerns must also be encouraged.
Several features of  our study deserve further comment. To 
our knowledge, this is the fi rst Portuguese study examining 
barriers to BP control in treated hypertensive outpatients in 
the Eastern Central Region of  Portugal. The study may be 
relevant to similar Caucasian populations in Portugal and 
other European countries. Other strengths were the high 
response rate and the 96.6% completion of  questionnaires. 
The limitations are the size of  the study, and the evaluation 
of  BP control based on the measurements performed in 
one single medical appointment. These BP measurements 
may or may not be representative of  the adequacy of  BP 
control in hypertensive patients. We also were unable to 
obtain objective measurements of  patient compliance 
(e.g., drug level in biologic fl uids, biologic markers, and 
direct patient observation) or to assess the attitudes of  the 
physicians and nurses toward patients. Behavioral models 
suggest that the most effective therapy prescribed by the 
most careful physician will control hypertension only if  the 
patient is motivated to take the medication as directed. [19] 
Motivation improves when patients have positive 
experiences with, and trust in, their health care professional 
team.[19] Moreover, a limited number of  covariates were 
analyzed. Undertreatment and clinical inertia are reported 
causes of  uncontrolled BP[24, 25] that were not evaluated 
in this cross-sectional study. Further, for some subgroup 
analyses, there were small cell sizes and the analyses must 
be considered exploratory in nature.
In conclusion, this study provides a framework for 
identifying hypertensive patients who are at high risk of  
poor BP control and since many of  the identifi ed factors are 
modifi able, they signal opportunities to improve BP control 
in clinical practice. Poor medication adherence and patient 
unawareness about target BP values, hypertension risks and 
antihypertensive drug indications, as well as the presence of  
drug side effects and lack of  regular BP monitoring should 
be considered as possible underlying causes of  inadequately 
controlled BP and must be addressed in any intervention 
aimed to improve BP control. Strategies to improve 
medication adherence must be reinforced. Self-monitoring 
with validated BP devices should be encouraged. Patients 
with poor knowledge of  the goal of  their hypertension 
therapy should be informed about their target BP, to enable 
them to participate more fully in their own management. 
To achieve the crucial objective of  improving health by 
controlling high BP, it is important to fully understand 
the current status of  patient knowledge, awareness, and 
attitudes with respect to hypertension, medication, and 
lifestyles. It is necessary to understand these patient factors 
to develop effective strategies and team-based health care 
professionals’ interventions that enroll the patient as a 
participant in the management of  his hypertension.
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